AR068187A1 - Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv - Google Patents
Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-ivInfo
- Publication number
- AR068187A1 AR068187A1 ARP080102995A ARP080102995A AR068187A1 AR 068187 A1 AR068187 A1 AR 068187A1 AR P080102995 A ARP080102995 A AR P080102995A AR P080102995 A ARP080102995 A AR P080102995A AR 068187 A1 AR068187 A1 AR 068187A1
- Authority
- AR
- Argentina
- Prior art keywords
- inhibitor
- preparation
- dpp
- crystal form
- crystalline form
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title abstract 2
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invencion provee una forma cristalina de un intermediario sintético de utilidad en la preparacion de un inhibidor de DPP-IV, un método de preparacion de la forma cristalina del intermediario y un método de uso de la forma cristalina del intermediario en la preparacion del inhibidor. Utiles para el tratamiento de la diabetes mellitus. Reivindicacion 1: Una forma cristalina de un compuesto de la formula (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95922607P | 2007-07-12 | 2007-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR068187A1 true AR068187A1 (es) | 2009-11-11 |
Family
ID=40229094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102995A AR068187A1 (es) | 2007-07-12 | 2008-07-11 | Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100204484A1 (es) |
EP (1) | EP2175727A4 (es) |
AR (1) | AR068187A1 (es) |
CA (1) | CA2692758A1 (es) |
CL (1) | CL2008002044A1 (es) |
MX (1) | MX2010000501A (es) |
TW (1) | TW200927144A (es) |
WO (1) | WO2009009751A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
JP5906086B2 (ja) | 2008-08-15 | 2016-04-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Fab関連疾患の治療に用いるためのプリン誘導体 |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
TWI466672B (zh) | 2009-01-29 | 2015-01-01 | Boehringer Ingelheim Int | 小兒科病人糖尿病之治療 |
CN106177958A (zh) | 2009-02-13 | 2016-12-07 | 勃林格殷格翰国际有限公司 | 包含dpp‑4抑制剂(利拉列汀)任选地组合其它抗糖尿病药的抗糖尿病药物 |
JP2013512229A (ja) | 2009-11-27 | 2013-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療 |
WO2011113947A1 (en) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
NZ602921A (en) | 2010-05-05 | 2016-01-29 | Boehringer Ingelheim Int | Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor |
MX2012014247A (es) | 2010-06-24 | 2013-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes. |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3496163A (en) * | 1965-02-08 | 1970-02-17 | Upjohn Co | 7-halo-7-deoxylincomycins and process for preparing the same |
US5329012A (en) * | 1987-10-29 | 1994-07-12 | The Research Foundation Of State University Of New York | Bis(acyloxmethyl)imidazole compounds |
US20100087658A1 (en) * | 1996-08-06 | 2010-04-08 | Phenomix Corporation | Methods and intermediates for synthesis of selective dpp-iv inhibitors |
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US7317109B2 (en) * | 2003-11-12 | 2008-01-08 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
US7576121B2 (en) * | 2003-11-12 | 2009-08-18 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
EP1919485A4 (en) * | 2005-08-01 | 2011-03-23 | Phenomix Corp | METHOD FOR PRODUCING HETEROCYCLIC BORONIC ACIDS AND ITS DERIVATIVES |
WO2007038676A2 (en) * | 2005-09-28 | 2007-04-05 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of ladostigil tartrate |
-
2008
- 2008-07-11 MX MX2010000501A patent/MX2010000501A/es not_active Application Discontinuation
- 2008-07-11 US US12/668,405 patent/US20100204484A1/en not_active Abandoned
- 2008-07-11 TW TW097126510A patent/TW200927144A/zh unknown
- 2008-07-11 CL CL2008002044A patent/CL2008002044A1/es unknown
- 2008-07-11 EP EP08826302A patent/EP2175727A4/en not_active Withdrawn
- 2008-07-11 CA CA 2692758 patent/CA2692758A1/en not_active Abandoned
- 2008-07-11 AR ARP080102995A patent/AR068187A1/es unknown
- 2008-07-11 WO PCT/US2008/069833 patent/WO2009009751A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20100204484A1 (en) | 2010-08-12 |
TW200927144A (en) | 2009-07-01 |
EP2175727A1 (en) | 2010-04-21 |
MX2010000501A (es) | 2011-05-25 |
WO2009009751A1 (en) | 2009-01-15 |
CL2008002044A1 (es) | 2009-01-16 |
EP2175727A4 (en) | 2011-05-25 |
CA2692758A1 (en) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR068187A1 (es) | Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv | |
CL2012001348A1 (es) | Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry. | |
ECSP12011935A (es) | Triazolopiridinas | |
AR053720A1 (es) | Forma cristalina de 1-cloro-4-((beta)-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofuran-3-iloxi)-bencil]-benceno, un metodo para su preparacion y el uso del mismo para preparar medicamentos | |
ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
DOP2009000266A (es) | Compuestos quimicos | |
CU20140068A7 (es) | Triazolopiridinas sustituidas | |
NO20090173L (no) | Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes | |
PA8666701A1 (es) | Nueva sal y polimorfos del inhibidor de la dpp-iv | |
UY29459A1 (es) | Forma cristalina ortorrómbica del maleato de asenapina y su uso en el tratamiento de trastornos mentales | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
WO2010063700A8 (en) | Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides | |
CR11232A (es) | Compuestos de tiazolopirina modulares de sirtuina | |
ECSP13013011A (es) | Triazolopiridinas | |
CY1114793T1 (el) | Παραγωγα αμινοπυραζολιου | |
ECSP12012338A (es) | Triazolopiridinas sustituidas | |
WO2009024342A3 (en) | Novel microbiocides | |
AR051043A1 (es) | Forma cristalina de clorhidrato de (3-cian-1h-indol-7il)-[4-(4-fluorofenetil)-piperazin-1-il]-metanona | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
DOP2009000207A (es) | Nueva forma de dosificación | |
WO2008151828A3 (en) | Novel microbiocides | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
WO2009127718A3 (en) | Novel microbiocides | |
BRPI0912388A2 (pt) | composto, forma cristalina, processo para preparar compostos, composição farmacêutica, e, uso de um composto, e, método para o tratamento ou profilaxia de doenças | |
ECSP10010168A (es) | Benzotiazolas como moduladores del receptor de ghrelina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |